Home » Topics » Regulatory

Regulatory
RSS

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

Harvard Scientific's liposomal prostaglandin E1 begins clinical trials

July 19, 1996

Alferon N injection undergoes phase III in HCV

July 19, 1996

SmithKline Beecham's new Havrix formulation receives Canadian approval

July 19, 1996

Trial results described for methylphenidate in head injury patients

July 19, 1996

Athena Neurosciences acquires worldwide rights to new formulation of Carbatrol

July 19, 1996

Pharmos receives grant to develop loteprednol/tobramycin combination product

July 19, 1996

Zadaxin/zidovudine/interferon alpha combination enhances immune system

July 19, 1996

Triple anti-HIV therapy shows positive results

July 19, 1996

Protease inhibitor plus Epivir/Retrovir cocktail shows positive anti-HIV results

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...